{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:50:03Z","timestamp":1785527403402,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2002,2,1]]},"DOI":"10.1038\/nbt0202-149","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:30:32Z","timestamp":1027672232000},"page":"149-154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells"],"prefix":"10.1038","volume":"20","author":[{"given":"Rong-Fu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnbt0202149_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1600-065X.1999.tb01331.x","volume":"170","author":"R-F Wang","year":"1999","unstructured":"Wang, R.-F. & Rosenberg, S.A. Human tumor antigens for cancer vaccine development. Immunol. Rev. 170, 85\u2013100 (1999).","journal-title":"Immunol. Rev."},{"key":"BFnbt0202149_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1084\/jem.183.3.725","volume":"183","author":"T Boon","year":"1996","unstructured":"Boon, T. & Van der Bruggen, P. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183, 725\u2013729 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1074-7613(00)80101-6","volume":"11","author":"E Gilboa","year":"1999","unstructured":"Gilboa, E. The makings of a tumor rejection antigen. Immunity 11, 263\u2013270 (1999).","journal-title":"Immunity"},{"key":"BFnbt0202149_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0952-7915(00)00195-3","volume":"13","author":"AN Houghton","year":"2001","unstructured":"Houghton, A.N., Gold, J.S. & Blachere, N.E. Immunity against cancer: lessons learned from melanoma. Curr. Opin. Immunol. 13, 134\u2013140 (2001).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnbt0202149_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0952-7915(00)00146-1","volume":"12","author":"RM Dallal","year":"2000","unstructured":"Dallal, R.M. & Lotze, M.T. The dendritic cell and human cancer vaccines. Curr. Opin. Immunol. 12, 583\u2013588 (2000).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnbt0202149_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1084\/jem.186.8.1183","volume":"186","author":"G Schuler","year":"1997","unstructured":"Schuler, G. & Steinman, R.M. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 186, 1183\u20131187 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245\u2013252 (1998).","journal-title":"Nature"},{"key":"BFnbt0202149_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1084\/jem.183.1.283","volume":"183","author":"CM Celluzzi","year":"1996","unstructured":"Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T. & Falo, L.D., Jr. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283\u2013287 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1084\/jem.183.1.317","volume":"183","author":"P Paglia","year":"1996","unstructured":"Paglia, P., Chiodoni, C., Rodolfo, M. & Colombo, M.P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183, 317\u2013322 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1084\/jem.183.1.7","volume":"183","author":"JW Young","year":"1996","unstructured":"Young, J.W. & Inaba, K. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 183, 7\u201311 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nm0398-328","volume":"4","author":"FO Nestle","year":"1998","unstructured":"Nestle, F.O. et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4, 328\u2013332 (1998).","journal-title":"Nat. Med."},{"key":"BFnbt0202149_CR12","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1084\/jem.190.11.1669","volume":"190","author":"B Thurner","year":"1999","unstructured":"Thurner, B. et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190, 1669\u20131678 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR13","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.4049\/jimmunol.165.5.2651","volume":"165","author":"M Bellone","year":"2000","unstructured":"Bellone, M. et al. Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma. J. Immunol. 165, 2651\u20132656 (2000).","journal-title":"J. Immunol."},{"key":"BFnbt0202149_CR14","first-page":"6995","volume":"60","author":"MW Schreurs","year":"2000","unstructured":"Schreurs, M.W. et al. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model. Cancer Res. 60, 6995\u20137001 (2000).","journal-title":"Cancer Res."},{"key":"BFnbt0202149_CR15","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.157.6.2539","volume":"157","author":"MR Parkhurst","year":"1996","unstructured":"Parkhurst, M.R. et al. Improved induction of melanoma reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A0201 binding residues. J. Immunol. 157, 2539\u20132548 (1996).","journal-title":"J. Immunol."},{"key":"BFnbt0202149_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nm0398-321","volume":"4","author":"SA Rosenberg","year":"1998","unstructured":"Rosenberg, S.A. et al. Immunologic and therapeutic evaluation of a synthetic tumor-associated peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4, 321\u2013327 (1998).","journal-title":"Nat. Med."},{"key":"BFnbt0202149_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1074-7613(00)00052-2","volume":"13","author":"JE Slansky","year":"2000","unstructured":"Slansky, J.E. et al. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC\u2013peptide\u2013TCR complex. Immunity 13, 529\u2013538 (2000).","journal-title":"Immunity"},{"key":"BFnbt0202149_CR18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4049\/jimmunol.162.1.168","volume":"162","author":"MS Labeur","year":"1999","unstructured":"Labeur, M.S. et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 162, 168\u2013175 (1999).","journal-title":"J. Immunol."},{"key":"BFnbt0202149_CR19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/42030","volume":"388","author":"M Cella","year":"1997","unstructured":"Cella, M., Engering, A., Pinet, V., Pieters, J. & Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782\u2013787 (1997).","journal-title":"Nature"},{"key":"BFnbt0202149_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-065X.1999.tb01305.x","volume":"169","author":"B Ludewig","year":"1999","unstructured":"Ludewig, B., Odermatt, B., Ochsenbein, A.F., Zinkernagel, R.M. & Hengartner, H. Role of dendritic cells in the induction and maintenance of autoimmune diseases. Immunol. Rev. 169, 45\u201354 (1999).","journal-title":"Immunol. Rev."},{"key":"BFnbt0202149_CR21","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","volume":"55","author":"AD Frankel","year":"1988","unstructured":"Frankel, A.D. & Pabo, C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189\u20131193 (1988).","journal-title":"Cell"},{"key":"BFnbt0202149_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0092-8674(00)81843-7","volume":"88","author":"G Elliott","year":"1997","unstructured":"Elliott, G. & O'Hare, P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88, 223\u2013233 (1997).","journal-title":"Cell"},{"key":"BFnbt0202149_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nbt0598-440","volume":"16","author":"A Phelan","year":"1998","unstructured":"Phelan, A., Elliott, G. & O'Hare, P. Intercellular delivery of functional p53 by the herpesvirus protein VP22 [see comments]. Nat. Biotechnol. 16, 440\u2013443 (1998).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt0202149_CR24","doi-asserted-by":"publisher","first-page":"14255","DOI":"10.1074\/jbc.270.24.14255","volume":"270","author":"YZ Lin","year":"1995","unstructured":"Lin, Y.Z., Yao, S.Y., Veach, R.A., Torgerson, T.R. & Hawiger, J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270, 14255\u201314258 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnbt0202149_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nbt0498-370","volume":"16","author":"M Rojas","year":"1998","unstructured":"Rojas, M., Donahue, J.P., Tan, Z. & Lin, Y.Z. Genetic engineering of proteins with cell membrane permeability. Nat. Biotechnol. 16, 370\u2013375 (1998).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt0202149_CR26","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1073\/pnas.91.2.664","volume":"91","author":"S Fawell","year":"1994","unstructured":"Fawell, S. et al. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91, 664\u2013668 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt0202149_CR27","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4049\/jimmunol.159.4.1666","volume":"159","author":"DT Kim","year":"1997","unstructured":"Kim, D.T. et al. Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. J. Immunol. 159, 1666\u20131668 (1997).","journal-title":"J. Immunol."},{"key":"BFnbt0202149_CR28","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","volume":"285","author":"SR Schwarze","year":"1999","unstructured":"Schwarze, S.R., Ho, A., Vocero-Akbani, A. & Dowdy, S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569\u20131572 (1999).","journal-title":"Science"},{"key":"BFnbt0202149_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0165-6147(00)01447-4","volume":"21","author":"M Lindgren","year":"2000","unstructured":"Lindgren, M., Hallbrink, M., Prochiantz, A. & Langel, U. Cell-penetrating peptides. Trends Pharmacol. Sci. 21, 99\u2013103 (2000).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnbt0202149_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1006\/mthe.2001.0279","volume":"3","author":"NJ Caron","year":"2001","unstructured":"Caron, N.J. et al. Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol. Ther. 3, 310\u2013318 (2001).","journal-title":"Mol. Ther."},{"key":"BFnbt0202149_CR31","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1084\/jem.184.6.2207","volume":"184","author":"R-F Wang","year":"1996","unstructured":"Wang, R.-F., Appella, E., Kawakami, Y., Kang, X. & Rosenberg, S.A. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. Exp. Med. 184, 2207\u20132216 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1084\/jem.185.3.453","volume":"185","author":"MB Bloom","year":"1997","unstructured":"Bloom, M.B. et al. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J. Exp. Med. 185, 453\u2013460 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR33","first-page":"4895","volume":"58","author":"MR Parkhurst","year":"1998","unstructured":"Parkhurst, M.R. et al. Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). Cancer Res. 58, 4895\u20134901 (1998).","journal-title":"Cancer Res."},{"key":"BFnbt0202149_CR34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4049\/jimmunol.162.2.989","volume":"162","author":"HJ Zeh","year":"1999","unstructured":"Zeh, H.J., Perry-Lalley, D., Dudley, M.E., Rosenberg, S.A. & Yang, J.C. High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J. Immunol. 162, 989\u2013994 (1999).","journal-title":"J. Immunol."},{"key":"BFnbt0202149_CR35","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","volume":"96","author":"WW Overwijk","year":"1999","unstructured":"Overwijk, W.W. et al. Vaccination with a recombinant vaccinia virus encoding a \u201cself\u201d antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA 96, 2982\u20132987 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt0202149_CR36","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1084\/jem.190.11.1717","volume":"190","author":"WB Bowne","year":"1999","unstructured":"Bowne, W.B. et al. Coupling and uncoupling of tumor immunity and autoimmunity. J. Exp. Med. 190, 1717\u20131722 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1084\/jem.185.2.317","volume":"185","author":"C Winzler","year":"1997","unstructured":"Winzler, C. et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185, 317\u2013328 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR38","first-page":"363","volume":"1","author":"PK Srivastava","year":"2000","unstructured":"Srivastava, P.K. Immunotherapy of human cancer: lessons from mice. Nat. Immunol. 1, 363\u2013366 (2000).","journal-title":"Nat. Immunol."},{"key":"BFnbt0202149_CR39","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.4049\/jimmunol.150.6.2169","volume":"150","author":"A Suhrbier","year":"1993","unstructured":"Suhrbier, A. et al. Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. Implications for peripheral T cell deletion and peptide vaccination. J. Immunol. 150, 2169\u20132178 (1993).","journal-title":"J. Immunol."},{"key":"BFnbt0202149_CR40","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/1521-4141(200106)31:6<1780::AID-IMMU1780>3.0.CO;2-I","volume":"31","author":"N Casares","year":"2001","unstructured":"Casares, N. et al. Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity. Eur. J. Immunol. 31, 1780\u20131789 (2001).","journal-title":"Eur. J. Immunol."},{"key":"BFnbt0202149_CR41","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1471-4906(01)01896-8","volume":"22","author":"R-F Wang","year":"2001","unstructured":"Wang, R.-F. The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity. Trends Immunol. 22, 269\u2013276 (2001).","journal-title":"Trends Immunol."},{"key":"BFnbt0202149_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0065-2776(08)60778-6","volume":"49","author":"PD Greenberg","year":"1991","unstructured":"Greenberg, P.D. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49, 281\u2013355 (1991).","journal-title":"Adv. Immunol."},{"key":"BFnbt0202149_CR43","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0952-7915(98)80228-8","volume":"10","author":"DM Pardoll","year":"1998","unstructured":"Pardoll, D.M. & Topalian, S.L. The role of CD4+ T cell responses in antitumor immunity. Curr. Opin. Immunol. 10, 588\u2013594 (1998).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnbt0202149_CR44","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1084\/jem.188.12.2357","volume":"188","author":"K Hung","year":"1998","unstructured":"Hung, K. et al. The central role of CD4+ T cells in the antitumor immune response. J. Exp. Med. 188, 2357\u20132368 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR45","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1084\/jem.189.5.753","volume":"189","author":"RE Toes","year":"1999","unstructured":"Toes, R.E., Ossendorp, F., Offringa, R. & Melief, C.J. CD4 T cells and their role in antitumor immune responses. J. Exp. Med. 189, 753\u2013756 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnbt0202149_CR46","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.186.8.1213","volume":"186","author":"JM Specht","year":"1997","unstructured":"Specht, J.M. et al. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med. 186, 1213\u20131221 (1997).","journal-title":"J. Exp. Med."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nbt0202-149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nbt0202-149","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nbt0202-149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:32:27Z","timestamp":1684863147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt0202-149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,1]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2,1]]}},"alternative-id":["BFnbt0202149"],"URL":"https:\/\/doi.org\/10.1038\/nbt0202-149","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2,1]]},"assertion":[{"value":"10 August 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}